Terns Pharmaceuticals
TERN
$7.25
Share price
-3.59%
Change (1 day)
-24.56%
Change (1 year)
Categories
Terns Pharmaceuticals (TERN) - Cash on Hand
Cash on Hand as of March 2024 : $0.24 B
According to Terns Pharmaceuticals's latest financial reports the company has $0.24 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Terns Pharmaceuticals - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.26 B | -6.95% |
| 2022-12-31 | $0.28 B | 70.57% |
| 2021-12-31 | $0.16 B | 121.74% |
| 2020-12-31 | $74.85 M | 280.94% |
| 2019-12-31 | $19.65 M | -77.38% |
| 2018-12-31 | $86.88 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 31.63% | 🇺🇸 USA |